Sanofi stock slumps after two setbacks on multiple-sclerosis drug
-
Shares of Sanofi slumped on Monday as the French drugmaker said a U.S.
regulatory review of its multiple-sclerosis drug won’t be completed by the
end of th...
23 minutes ago





http://youtu.be/ptX6QwRjAIo
ReplyDelete